Park Alyssa M, Storm Douglas W, Fulmer Brant R, Still Christopher D, Wood G Craig, Hartle James E
Geisinger Medical Center, Danville, Pennsylvania 17822, USA.
J Urol. 2009 Nov;182(5):2334-9. doi: 10.1016/j.juro.2009.07.044. Epub 2009 Sep 16.
Roux-en-Y gastric bypass surgery has become an increasingly common form of weight management. Early retrospective reviews have suggested that new onset nephrolithiasis develops in some patients after undergoing Roux-en-Y gastric bypass. We present a prospective longitudinal study to assess risk factors for nephrolithiasis after Roux-en-Y gastric bypass.
A total of 45 morbidly obese patients scheduled to undergo Roux-en-Y gastric bypass surgery were enrolled in this prospective study between November 2006 and November 2007. Exclusion criteria included history of nephrolithiasis or inflammatory bowel disease. Serum uric acid, parathyroid hormone, calcium, albumin, and creatinine and 24-hour urine collections were obtained within 6 months before Roux-en-Y gastric bypass, and at 6 to 12 months postoperatively. A Wilcoxon signed-rank test was used to compare preoperative and postoperative serum laboratory values and 24-hour urine values. McNemar's test was used to determine if the percent of abnormal values underwent a statistically significant change after Roux-en-Y gastric bypass. For both statistical methods a p value was calculated for the change in each variable with p <0.05 considered statistically significant.
Statistically significant changes included increased urinary oxalate and calcium oxalate supersaturation, and decreased urinary citrate and total urinary volume postoperatively. A statistically significant percentage of patients exhibited decreased urinary calcium, while a statistically significant percentage of patients experienced increased urinary oxalate and calcium oxalate supersaturation.
Our prospective study demonstrated multiple factors that increase the relative risk of nephrolithiasis after Roux-en-Y gastric bypass. These changes may make stone formation after Roux-en-Y gastric bypass increasingly likely and pose an ongoing challenge in the realm of urology.
Roux-en-Y胃旁路手术已成为一种越来越常见的体重管理方式。早期的回顾性研究表明,一些患者在接受Roux-en-Y胃旁路手术后会出现新发肾结石。我们开展了一项前瞻性纵向研究,以评估Roux-en-Y胃旁路手术后肾结石的危险因素。
2006年11月至2007年11月期间,共有45例计划接受Roux-en-Y胃旁路手术的病态肥胖患者纳入了这项前瞻性研究。排除标准包括肾结石病史或炎症性肠病病史。在Roux-en-Y胃旁路手术前6个月内以及术后6至12个月时,获取血清尿酸、甲状旁腺激素、钙、白蛋白、肌酐以及24小时尿液样本。采用Wilcoxon符号秩检验比较术前和术后的血清实验室值及24小时尿液值。使用McNemar检验确定Roux-en-Y胃旁路手术后异常值百分比是否发生了具有统计学意义的变化。对于这两种统计方法,计算每个变量变化的p值,p<0.05被认为具有统计学意义。
具有统计学意义的变化包括术后尿草酸和草酸钙过饱和度增加,以及尿柠檬酸盐和总尿量减少。有统计学意义百分比的患者尿钙降低,而有统计学意义百分比的患者尿草酸和草酸钙过饱和度增加。
我们的前瞻性研究证明了多个增加Roux-en-Y胃旁路手术后肾结石相对风险的因素。这些变化可能使Roux-en-Y胃旁路手术后结石形成的可能性增加,并在泌尿外科领域构成持续挑战。